Phage Study

Phage Study

by Adaptive Phage Therapeutics, Inc

1 ratings
Free

Rating summary
1
0
0
0
0

Details

  • Released
  • Updated
  • December 11, 2022
  • November 12, 2023

Features

Phage Study screenshot #1 for iPhone
Phage Study screenshot #2 for iPhone
Phage Study screenshot #3 for iPhone
Phage Study screenshot #4 for iPhone
Phage Study screenshot #5 for iPhone
Phage Study screenshot #6 for iPhone
Phage Study screenshot #7 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

Access information about clinical studies focused on using bacteriophages to combat multi-drug resistant infections. This utility provides details on ongoing research and treatment approaches.

Clinical study information
Phage therapy details
Multi-drug resistant infections
Research updates
Show original description

What's New in Phage Study

1.1.4

November 12, 2023

Minor change to remove information from inactive studies.

FAQ

What is Phage Study used for?

Phage Study provides information regarding clinical studies that use bacteriophages to treat multi-drug resistant infections. It details ongoing research and treatment approaches in this area.

Is Phage Study free to use?

Yes, Phage Study is available for free. It does not require any payment to access its information.

What devices is Phage Study compatible with?

Phage Study is designed for iOS devices, including iPhone, iPad, and iPod. It requires iOS 17+.

How often is Phage Study updated?

The app was last updated on November 12, 2023, with version 1.1.4. This indicates regular maintenance and potential for future updates.

What is the age rating for Phage Study?

Phage Study has an age rating of 17+. This suggests the content may be more relevant to adults or those with a specific interest in medical research.

Who developed Phage Study?

Phage Study was developed by Adaptive Phage Therapeutics, Inc., a company focused on phage-based therapies.

Does Phage Study have ads?

No, Phage Study does not contain advertisements. Users can access information without interruption.